MktsMarkets

CG Oncology, Inc.
NASDAQ: CGONKey statistics
CGON News
Stories mentioning CGON from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 43,730 | 29,959 | 27,884 | 31,331 | 27,467 | 26,800 | 19,622 | 18,470 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 48,741 | 42,256 | 38,505 | 28,338 | 25,964 | |||
| Operating Income (Loss) | (66,389) | (48,700) | (51,129) | (48,741) | (42,204) | (38,049) | (28,295) | (25,853) |
| Interest Income | 6,288 | 7,444 | 7,421 | 7,319 | 7,747 | 6,245 | 7,892 | 6,943 |
| Interest Expense | ||||||||
| Other Expense | (101.00) | (53.00) | (100.00) | (4.00) | 5.00 | 6.00 | (2.00) | 8.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (60,202) | (41,309) | (43,808) | (41,426) | (34,452) | (31,798) | (20,405) | (18,902) |
| Earnings Per Share (Basic) | (0.71) | (0.53) | (0.57) | (0.54) | (0.45) | (0.51) | (0.30) | (0.28) |
| Earnings Per Share (Diluted) | (0.71) | (0.53) | (0.57) | (0.54) | (0.45) | (0.51) | (0.30) | (0.28) |
| Weighted Average Shares Outstanding (Basic) | 84,519 | 77,303 | 76,730 | 76,227 | 76,188 | 62,497 | 67,144 | 66,649 |
| Weighted Average Shares Outstanding (Diluted) | 84,519 | 77,303 | 76,730 | 76,227 | 76,188 | 62,497 | 67,144 | 66,649 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CGON
CG Oncology, Inc. (NASDAQ: CGON) is a stock listed on the Nasdaq Stock Market under the ticker symbol CGON. It last traded at $75.99 (Nov 6, 2026, 4:00 PM ET), up 17.3% on the day. That gives CG Oncology a market capitalisation of $6.8B.
Over the past 52 weeks CGON has traded between $35.80 and $80.97.
For the quarter ended Mar 31, 2026 it reported a net loss of $60.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$60.2M |
| Dec 31, 2025 | — | -$41.3M |
| Sep 30, 2025 | — | -$43.8M |
| Jun 30, 2025 | — | -$41.4M |
From CG Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…